SCP
ACHV icon

Steamboat Capital Partners’s Achieve Life Sciences ACHV Stock Holding History

Steamboat Capital Partners’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-372
Closed -$414K – 19
2016
Q3 		$414K Buy
+372
New +$593K 0.37% 14

Other funds holding ACHV

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Steamboat Capital Partners's ACHV Position: Q4 2016 in Review

Steamboat Capital Partners sold out of Achieve Life Sciences (ACHV) in Q4 2016, closing a stake of 372 shares — an estimated $414K sold.

Steamboat Capital Partners first reported a position in ACHV in Q3 2016 and held it in 1 quarter. The position peaked at $414K in Q3 2016. 29 funds tracked by Wall St. Rank hold ACHV as of Q4 2016.

  • Steamboat Capital Partners reported no remaining Achieve Life Sciences position as of Q4 2016 after selling out during the quarter.
  • Steamboat Capital Partners sold 372 Achieve Life Sciences shares in Q4 2016, an estimated $414K.
  • Steamboat Capital Partners first reported a position in Achieve Life Sciences in Q3 2016 and held it in 1 quarter.
  • Steamboat Capital Partners's Achieve Life Sciences position peaked at $414K in Q3 2016.
  • 29 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2016.

Based on Steamboat Capital Partners's 13F filing for Q4 2016, filed 14 Feb 2017.